Lansoprazole Delayed-release Capsules — Class II drug recall D-147-2013
Terminated recall by Mylan Pharmaceuticals Inc., reported 2013-02-13, distributed nationwide. Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topir
| Recall number | D-147-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mylan Pharmaceuticals Inc., Morgantown, WV, United States |
| Recall initiated | 2013-01-30 |
| Classified | 2013-02-05 |
| Reported by FDA | 2013-02-13 |
| Terminated | 2013-12-23 |
| Distributed | Nationwide (US) |
| Quantity | 1,894 bottles |
| NDC | 00378-8015, 00378-8015-93, 00378-8030, 00378-8030-05, 00378-8030-77, 00378-8030-93 |
| Lot numbers | 05/14, 1110829 |
Product
Lansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Made in India, NDC 0378-8030-05.
Reason for recall
Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-147-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.